SCHEMBL19783689

SCHEMBL19783689

COC(=O)COc1cc2sc(Br)nc2c(Cl)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.37
TSHR P16473 2/20 0.37
CYP1A2 P05177 2/20 0.36
MEN1 O00255 2/20 0.36
CYP2C9 P11712 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 2/20 0.36
PTGDR Q13258 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
CASP1 P29466 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPK1 P28482 1/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782421 0.89 LMNA (0.41) LMNAALDH1A1HPGDGAAKDM4E
SCHEMBL19782970 0.87 LMNA (0.44) LMNAALDH1A1HPGDGAAKDM4E
SCHEMBL19782757 0.83 LMNA (0.39) LMNAALDH1A1HPGDGAAKDM4E
SCHEMBL19783026 0.80 PDE10A (0.32) KMT2A
SCHEMBL19782781 0.79 MAPT (0.38) ALDH1A1GAAKDM4EKMT2ATSHR
SCHEMBL19783184 0.74 LMNA (0.43) LMNAALDH1A1HPGDGAAKDM4E
SCHEMBL21395798 0.73 MAPT (0.34) ALDH1A1GAAKMT2AMAPK1SMN1; SMN2
SCHEMBL19783084 0.72 PKM (0.42) ALDH1A1HPGDKDM4EPOLBTSHR
SCHEMBL19782976 0.72 LMNA (0.40) LMNAALDH1A1KDM4EKMT2APOLB
SCHEMBL19783010 0.71 KMT2A (0.32) LMNAALDH1A1HPGDGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 LMNA 745/4885ALDH1A1 1618/4885HPGD 866/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 LMNA 603/4885ALDH1A1 1598/4885HPGD 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.